The Role of Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus
Vivian Fonseca, MD
Basal insulins, both intermediate- and long-acting formulations, are playing an increasingly important role in the treatment of type 2 DM.
Clinical Inertia: Overcoming a Major Barrier to Diabetes Management
Charles F. Shaefer, Jr., MD, FCCP, FACP
Although various psychological and system barriers can slow the physician from rapidly achieving established therapeutic goals, the simple strategies outlined here can eliminate many of the confounding factors that hinder aggressive management.
A Case for Introducing Insulin Early in the Treatment of Type 2 Diabetes Mellitus
Sydney A. Westphal, MD, Pasquale J. Palumbo, MD
With a more aggressive approach to starting and intensifying insulin therapy, patients may be more likely to achieve and maintain glycemic goals, thereby reducing the development of DM complications. Over time, this intervention may lead to healthier and longer lives for patients with type 2 DM.
Narrowing the Cultural Divide in Diabetes Mellitus Care: A Focus on Improving Cultural Competency to Better Serve Hispanic/Latino Populations
Carlos Campos, MD, MPH
Effective communication by DM care providers and efforts to improve health literacy among patients can often lead to improvements in DM management, with an emphasis on achieving glycemic control and reducing the risk for DM-related complications.
Response to Previous Case Study
Derek LeRoith, MD, PhD
Rocio Pereira presents an interactive case study involving the use of insulin in a 29-year-old Hispanic woman with DM. Readers are encouraged to consider the accompanying questions and to submit their response for consideration by a diabetes expert.
|